超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

比利時瓦隆州的生命科學(xué)競爭力中心BioWin  
BioWin 位于布魯塞爾南部,是比利時瓦隆州的優(yōu)勢健康產(chǎn)業(yè)園區(qū)。作為歐洲最具創(chuàng)新能力的生物技術(shù)中心之一，瓦隆州在比利時享有獨特地位。120 余家健康產(chǎn)業(yè)公司落戶于
此，專注于健康生物技術(shù)和醫(yī)療技術(shù)的發(fā)展。
涵蓋領(lǐng)域包括生物醫(yī)藥、細胞治療、放射性藥物、診斷、生物技術(shù)產(chǎn)品、醫(yī)療儀器和設(shè)備 等 ，并提供委外研發(fā)（ CRO ）、 委外制造（CMO）和生物信息學(xué)服務(wù)。

我們在健康相關(guān)的生物技術(shù)領(lǐng)域擁有諸多優(yōu)勢： 優(yōu)秀的學(xué)術(shù)和產(chǎn)業(yè)研究能力；獨特的學(xué)術(shù)及產(chǎn)業(yè)合作網(wǎng)絡(luò)； 高度集中的大學(xué)附屬醫(yī)院（比利時是世界上人均臨床試驗比例最高的國家，也是歐洲一期臨床試驗審批速度最快的國家：僅需兩周?。?；擁有孵化器和創(chuàng)新中心的科技園區(qū)，成本合理、選擇范圍廣。

瓦隆州集諸多優(yōu)勢于一身， 是名副其實的產(chǎn)業(yè)必爭之地。


今天的 BioWin=510 個成員
120 家企業(yè)
銷售額： 30 億歐元/年
就業(yè)： 14,500 個直接就業(yè)崗位
私人研發(fā)投資：15 億歐元/年
3 個大學(xué)學(xué)術(shù)團體
來自 3 個大學(xué)學(xué)術(shù)團體的 400 家研究單位
11,000 名研究人員
公共研發(fā)投資：1.65 億歐元/年

BioWin is the Health competitiveness cluster of Wallonia, the region to the south of Brussels in Belgium.

Created in July 2006, its role is to bring together all the Walloon stakeholders participating in innovative projects and/or training in the fields of biotechnology and healthcare.

Its aims are: 

 

• To create a new culture of openness and of partnership in order to foster innovation in Wallonia.

• To form, attract and conserve first-rate human capital in Wallonia.

• To assist with the creation of collective infrastructure and technological platforms.

• To promote Wallonia’s strengths in the fields of biotechnology for healthcare and medical technology internationally.

BioWin is the acronym of BIOtechnologies Wallonie INnovation. The members of BioWin are active in the main healthcare biotechnology sectors, namely: (bio)pharmacy, cell therapy, radiopharmacy, diagnostics, biotech products, services (CRO, CMO), medical devices and equipment. 

They are all innovators, both in research and development and in production. You can find the complete and detailed list of members on the website under the "Members" tab. 

Wallonia has good reason to be proud of its long tradition of excellence in the field of Healthcare biotechnologies. World leaders such as GSK Biologicals (vaccines), UCB(biopharmacy) and IBA (cancer diagnostics and treatments) are companies that have grown out of the local scientific and industrial scene and who have developed in the region. Around 30% of employees of these companies are still dedicated to R&D.Baxter (biopharmacy, medical devices) has been working in Wallonia for more than 30 years (R&D and production) and continues to make long-term investments here. Alongside these large industrial players, there is a rich network of SMEs, including numerous university spin-offs.

Regarding teaching and research, seven universities grouped into three academic consortia based at the universities of Brussels (ULB), Liège (ULg) and Louvain (UCL) also have a long history of cultivating scientific excellence in the biomedical subject areas.

In addition, several internationally renowned research institutes are based in Brussels and in the Walloon region:

 

• Ludwig Institute of Cancer Research (LICR)

• Christian De duve Institute of Cellular Pathology (ICP)

• Institute for Medical Immunology (IMI)

• Grappe Interdisciplinaire de Génoprotéomique Appliquée (Interdisciplinary Cluster for Applied Genoproteonics) (GIGA)

• Institut de Biologie et de Médecine Moléculaire (Institute of Biology and Molecular Medicine) (IBMM)

• Institut de Recherche Interdisciplinaire de Biologie Humaine et Moléculaire (Institute for Interdisciplinary Research in Human and Molecular Biology) (IRIBHM)

• Centre de Microscopie et d'Imagerie Moléculaire (Centre for Microscopy and Molecular Imagery) (CMMI)

• Inter-university institute for research in the life sciences “WELBIO”